Indee Labs

Winter 2017Active

Enabling T cell immunotherapy discovery, development and manufacturing

Save

Indee Labs

Winter 2017Active

Enabling T cell immunotherapy discovery, development and manufacturing

Save

Company details

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Location

San Francisco, CA, USA; Berkeley, CA, USA

Founded

Unknown

Request the Indee Labs report.

Indee Labs has no report yet. Sign in with your email to request one.